Final results of a phase III randomized study of concurrent weekly cisplatin-RT versus RT alone in locoregionally advanced nasopharyngeal carcinoma (NPC).

被引:0
|
作者
Chan, AT
Ngan, R
Teo, P
Leung, SF
Yiu, HY
Yeo, W
Mok, T
Cheung, FY
Kwan, W
Zee, B
机构
[1] Chinese Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China
[2] Queen Elizabeth Hosp, Hong Kong, Hong Kong, Peoples R China
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
5523
引用
收藏
页码:493S / 493S
页数:1
相关论文
共 50 条
  • [21] Results of a randomized phase III study of nimotuzumab in combination with concurrent radiotherapy and cisplatin versus radiotherapy and cisplatin alone, in locally advanced squamous cell carcinoma of the head and neck.
    Patil, Vijay Maruti
    Noronha, Vanita
    Joshi, Amit
    Agarwal, Jaiprakash
    Laskar, Sarbani Ghosh
    Budrukkar, Ashwini
    Murthy, Vedang
    Kannan, Sadhana
    Bhattacharjee, Atanu
    Chaturvedi, Pankaj
    Pai, P. S.
    Chaukar, Devendra
    D'cruz, Anil K.
    Juvekar, S.
    Manjrekar, Aparna
    Mathrudev, Vijayalakshmi
    Nawale, Kavita Prakash
    Bhelekar, Arti
    Banavali, Shripad Dinanath
    Prabhash, Kumar
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [22] Preliminary results of a phase III randomized study comparing chemotherapy neoadjuvantly or concurrently with radiotherapy for locoregionally advanced nasopharyngeal carcinoma
    Tingting Xu
    Chaosu Hu
    Guopei Zhu
    Xiayun He
    Yongru Wu
    Hongmei Ying
    Medical Oncology, 2012, 29 : 272 - 278
  • [23] Preliminary results of a phase III randomized study comparing chemotherapy neoadjuvantly or concurrently with radiotherapy for locoregionally advanced nasopharyngeal carcinoma
    Xu, Tingting
    Hu, Chaosu
    Zhu, Guopei
    He, Xiayun
    Wu, Yongru
    Ying, Hongmei
    MEDICAL ONCOLOGY, 2012, 29 (01) : 272 - 278
  • [24] Preliminary report of randomized phase II clinical study comparing standard radiotherapy with or without weekly oxaliplatin in treatment of locoregionally advanced nasopharyngeal carcinoma (NPC)
    Zhang, L.
    Zhao, C.
    Peng, P. J.
    Lu, L. X.
    Huang, P. Y.
    Han, F.
    Wu, S. X.
    EJC SUPPLEMENTS, 2005, 3 (02): : 289 - 289
  • [25] Exploratory Study of NPC-0501 Trial: Optimal Cisplatin Dose of Concurrent and Induction/Adjuvant Chemotherapy for Locoregionally Advanced Nasopharyngeal Carcinoma
    Ng, Wai-Tong
    Choi, Cheuk-Wai
    But, Barton
    Ngan, Roger K. C.
    Tung, Stewart
    Cheng, Ashley C.
    Kwong, Dora L. W.
    Lu, Tai-Xiang
    Chan, Anthony T. C.
    Yiu, Harry
    Lee, Sarah
    Wong, Frank
    Yuen, Kam-Tong
    Chappell, Richard J.
    Lee, Anne W. M.
    CLINICAL CANCER RESEARCH, 2022, 28 (12) : 2679 - 2689
  • [26] Overall survival after concurrent cisplatin-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma
    Chan, ATC
    Leung, SF
    Ngan, RKC
    Teo, PML
    Lau, WH
    Kwan, WH
    Hui, EP
    Yiu, HY
    Yeo, W
    Cheung, FY
    Yu, KH
    Chiu, KW
    Chan, DT
    Mok, TSK
    Yau, S
    Yuen, KT
    Mo, FKF
    Lai, MMP
    Ma, BBY
    Kam, MKM
    Leung, TWT
    Johnson, PJ
    Choi, PHK
    Zee, BCY
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (07) : 536 - 539
  • [28] Induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: Long-term results of a phase 3 multicenter randomized controlled trial.
    Chen, Ming-Yuan
    Yang, Qi
    Hong, Minghuang
    Hong, Ming-Huang
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [29] Radiation therapy concurrent with weekly paclitaxel for locoregionally advanced nasopharyngeal carcinoma - Outcomes of a Phase I Trial
    Chen, M
    Wu, SX
    Chen, YY
    Lu, LX
    Bao, Y
    Lin, HX
    Xian, CG
    Li, Q
    Deng, XW
    Lu, TX
    Cui, NJ
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2004, 27 (05): : 481 - 484
  • [30] Concurrent chemoradiotherapy with 3-weekly versus weekly cisplatin in patients with locoregionally advanced nasopharyngeal carcinoma: A phase 3 multicentre randomised controlled trial (ChiCTR-TRC-12001979).
    Liang, Hu
    Xia, Wei-Xiong
    Lv, Xing
    Sun, Rui
    Zeng, Qi
    Li, Si -Wei
    Mo, Hao-Yuan
    Han, Fei
    Luo, Dong-Hua
    Ye, Yan-Fang
    Yang, Jing
    Ke, Liang-Ru
    Guo, Ling
    Chen, Ming-Yuan
    Cao, Ka-Jia
    Zhao, Chong
    Mai, Hai-Qiang
    Qian, Chao-Nan
    Guo, Xiang
    Yanqun, Xiang
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35